Ownership

Charles Theuer - Insider Trading & Ownership

Entity: Individual
Location: C/O Tracon Pharmaceuticals, Inc., 4350 La Jolla Village Drive, Suite 800, San Diego, CA
Summary: The estimated net worth of Charles Theuer is at least $54.2K dollars as of June 24, 2024. Charles Theuer is the PRESIDENT AND CEO, Director of Tracon Pharmaceuticals, Inc. and owns shares of Tracon Pharmaceuticals, Inc. (TCON) stock worth about $54.2K.
All Insider Reports: All Insider Reports

Ownership of Charles Theuer

Symbol	Company	Relationship	Holdings Value	Report Period
TCON	Tracon Pharmaceuticals, Inc.	PRESIDENT AND CEO, Director	$54.2K	Mar 12, 2024
FDMT	4D Molecular Therapeutics, Inc.	Director		May 21, 2024
ONCT	Oncternal Therapeutics, Inc.	Director		Jun 20, 2024

Showing 1 to 3 of 3 entries

Insider Transactions Reported by Charles Theuer:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
ONCT	Oncternal Therapeutics, Inc.	Stock Options	Award		$0	0.00	+2.2K	2.2K	6/20/2024	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right To Buy)	Award		$0	0.00	+22.5K	22.5K	5/21/2024	Direct
TCON	Tracon Pharmaceuticals, Inc.	Employee Stock Option (Right to Buy)	Award		$0	0.00	+518K	518K	3/12/2024	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Award	+0.87%	$467	0.13	+3.5K	406K	10/20/2023	Direct
ONCT	Oncternal Therapeutics, Inc.	Stock Options	Award		$0	0.00	+25K	25K	6/28/2023	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/23/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+13.3%	$35.3K	0.75	+47K	399K	4/27/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.15%	$2.64K	0.66	+4K	352K	4/26/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Award	+0.88%	$482	0.14	+3.5K	403K	4/20/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.41%	$7.3K	1.52	+4.8K	345K	3/1/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+0.06%	$304	1.52	+200	340K	2/28/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Employee Stock Option (Right to Buy)	Award		$0	0.00	+332K	332K	2/1/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+2.04%	$11K	1.62	+6.8K	340K	1/18/2023	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+7.42%	$29.8K	1.29	+23K	333K	12/14/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+4.69%	$19.6K	1.41	+13.9K	310K	11/18/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+3.21%	$14K	1.52	+9.2K	296K	11/3/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+2.14%	$9.54K	1.59	+6K	287K	11/2/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.83%	$8.85K	1.77	+5K	278K	10/7/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.87%	$8.35K	1.67	+5K	273K	10/3/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.9%	$8.8K	1.76	+5K	268K	9/22/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.74%	$8.33K	1.85	+4.5K	263K	7/22/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.18%	$5.52K	1.84	+3K	258K	7/13/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.19%	$5.61K	1.87	+3K	255K	7/12/2022	Direct
ONCT	Oncternal Therapeutics, Inc.	Stock Options	Award		$0	0.00	+25K	25K	6/16/2022	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/23/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+4.13%	$18.5K	1.85	+10K	252K	5/9/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.04%	$4.93K	1.97	+2.5K	242K	5/6/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+2.13%	$9.86K	1.97	+5K	240K	4/29/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.96%	$10.4K	2.30^*	+4.5K	235K	4/21/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+0.89%	$5K	2.50^*	+2K	227K	4/8/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.81%	$10.8K	2.70^*	+4K	225K	3/30/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+0.55%	$2.94K	2.45^*	+1.2K	221K	3/21/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Employee Stock Option (Right to Buy)	Award		$0	0.00	+265K	265K	1/28/2022	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.62%	$9.87K	2.82^*	+3.5K	219K	11/19/2021	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+0.32%	$1.96K	2.88^*	+681	216K	11/18/2021	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.89%	$13.7K	3.41	+4K	215K	11/5/2021	Direct
TCON	Tracon Pharmaceuticals, Inc.	Common Stock	Purchase	+1.47%	$10.7K	3.56	+3K	208K	8/16/2021	Direct
ONCT	Oncternal Therapeutics, Inc.	Stock Options	Award		$0	0.00	+25K	25K	5/25/2021	Direct
FDMT	4D Molecular Therapeutics Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/17/2021	Direct

Previous1Next

Showing 1 to 39 of 39 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.